Andrea Charles | 10/27/2011
Dr. Till Kühn, Product Manager at Bruker Biospin, speaks to Andrea Charles from Pharma IQ, about recent NMR spectroscopy trends such as higher sensitivity , smaller sample sizes and automation and the challenges routine NMR users face in their daily workflow of spectral interpretation. In the second part of the interview Kühn discusses how Bruker are seeking to address these challenges with CMC-assist and what further improvements he thinks we will see in ana...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
SmartLab Exchange USA
April 20-21, 2026
The Logan, Philadelphia, USA
Register Now |
View Agenda |
Learn More